HopeStage
Back to all studies
RecruitingNCT07176351

Monthly buprenorphine injections from a mobile pharmacy clinic

About this titleRead the official source — NCT07176351
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

What will I do during this study?

This six-month prospective study takes place through a mobile pharmacy clinic. Participants discuss options with a clinician and can choose whether to start weekly or monthly extended-release buprenorphine injections; dosing is based on medical need. The study collects medical-visit and medical-record data during follow-up.

Listed locations
New HavenSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 23, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07176351
Official title
Show the full official title

Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic: A Pilot Study

Recruitment & locations

Currently recruiting

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Does this study involve medication?

Yes. The study involves medication, including Buprenorphine.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies